Project Get Fit With MS: Guidelines for Exercise Training and Fitness Outcomes in MS (GetFit)
Project GET FIT With MS: Guidelines for Exercise Training and Fitness Outcomes in MS
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
Illinois
-
Urbana-Champaign, Illinois, United States, 61801
- University of Illinois at Urbana-Champaign
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- a definite diagnosis of MS
- self-reported Expanded Disability Status Scale (EDSS) score < 6.0 or Patient Determined Disability Steps (PDDS) scale score ≤ 3.0
- relapse free in past 30 days
- willing and able to visit the University of Illinois at Urbana-Champaign for on seven occasions (two testing visits; five training visits) and participate in a 6-month home-based exercise program
- non-exerciser
- asymptomatic and physician approval for undertaking exercise testing and training
Exclusion Criteria:
- currently pregnant
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Stretching exercise
The stretching condition will consist of 1-3 sets, 30-40 seconds of 12 stretching movements targeting lower body, upper body, and core areas performed 2 days per week.
|
The stretching condition will consist of 1-3 sets, 30-40 seconds of 12 stretching movements targeting lower body, upper body, and core areas performed 2 days per week.
|
|
Experimental: Resistance exercise
The resistance condition will consist of 1-3 sets, 10-15 repetitions of 12 exercises targeting lower body, upper body, and core muscle groups performed 2 days per week.
|
strength training consists of 1-3 sets , 10-15 repetitions of 10 exercises targeting lower body, upper body and core muscle groups
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physical fitness (aerobic and muscular)
Time Frame: 0 and 6 months
|
Physical fitness determined by VO2 peak using a computer-driven cycle ergometer Muscular fitness determined by a seated dynamometer machine for leg strength and a hand dynamometer for upper body strength
|
0 and 6 months
|
|
Walking and physical function
Time Frame: 0 and 6 months
|
A timed 25-Foot walk, a 6 -minute walk, walking on a GaitRite electronic walkway, 9-hole peg test and the use of a force platform will measure walking and physical function.
|
0 and 6 months
|
|
Cognition
Time Frame: 0 and 6 months
|
The Brief International Cognitive Assessment for MS battery will be used.
|
0 and 6 months
|
|
Physical activity
Time Frame: 0 and 6 months
|
an accelerometer along with the Godin Leisure Time Physical Activity Questionnaire and 7-day Physical Activity Recall Questionnaire will be used to measure physical activity.
|
0 and 6 months
|
|
Patient-rated outcomes
Time Frame: 0 and 6 months
|
Self reporting questionnaires on fatigue, mobility, anxiety, depression, QoL, and social cognitive theory variable (e.g.
Exercise Self-Efficacy Scale, Late-life function and disability scale)
|
0 and 6 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body composition
Time Frame: 0 and 6 months
|
DXA scan
|
0 and 6 months
|
|
OCT Eye imaging
Time Frame: 0 and 6 months
|
0 and 6 months
|
|
|
Cardiovascular function
Time Frame: 0 and 6 months
|
ultrasonography techniques for arterial size, stiffness and blood pressure along with an ECG
|
0 and 6 months
|
|
Blood biomarkers
Time Frame: 0 and 6 months
|
Circulating inflammatory markers, cytokines and growth factors
|
0 and 6 months
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Neurological examination
Time Frame: 0 and 6 months
|
0 and 6 months
|
|
|
Exercise training parameters
Time Frame: 24 weeks
|
strength-training program or a stretching and limbering program
|
24 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Lara Pilutti, PhD, University of Illinois at Urbana-Champaign
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- NMSS IL-0010
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.